A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.
Inclusion Criteria:
Exclusion Criteria:
RA.ctaRichter@richter.hu+36 1 432 6437
Barranquilla, 080020, Colombia
Guanajuato City, 37000, Mexico
Timișoara, 300230, Romania
Arkhangelsk, 163530, Russia
Lipetsk, 399083, Russia
Roshchino, 188820, Russia
Saint Petersburg, 190121, Russia
Saint Petersburg, 192019, Russia
Saint Petersburg, 197022, Russia
Saint Petersburg, 197341, Russia
Saratov, 410028, Russia
Yaroslavl Region, 634009, Russia
Kharkiv, 61068, Ukraine
Kharkiv, 61153, Ukraine
Lviv, 79021, Ukraine